Skip to main navigation Skip to search Skip to main content

Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111

Project: Research

Project Details

StatusActive
Effective start/end date11/29/22 → 03/30/28

Funding

  • Hoosier Cancer Research Network Incorporated